Check out which companies are making headlines before the bell:
Intercept Pharmaceuticals—The company released positive data on a drug designed to treat a liver disease called nonalcoholic steatohepatitis, or "NASH."
related investing news
Exact Sciences–The FDA has approved the company's non-invasive test for colorectal cancer.
Abercrombie & Fitch–Stifel Nicolaus upgraded the clothing retailer's stock to "buy" from "hold," citing a favorable change in Abercrombie's merchandise mix.
Williams-Sonoma–Citi calls the retailer its top back-to-school season pick, specifically because of the prospects for its Pottery Barn unit. In its report, Citi also calls Macy's, L Brands, Fossil, and Sally Beauty back-to-school season buys.
Skullcandy–The maker of headphones was upgraded to "hold" from "underperform" at Jefferies, which cites sustained fundamental improvement. However, the firm also cautions that "the road to recovery is long."
Towers Watson–The consulting firm reported fiscal fourth quarter profit of $1.34 per share, excluding certain items, nine cents above estimates. Revenue also came in above forecasts, even though Tower said it has experienced some "pressure on revenues" over the past year.
Nuance Communications—The maker of speech recognition software reporting fiscal third quarter profit of 27 cents per share, excluding certain items, matching estimates. However, its revenue was below Street forecasts, as is its current quarter revenue and earnings forecast. Nuance is the company whose software powers Apple's Siri feature on iPhones and iPads.
Tesla–The Model S sedan is the subject of a new Consumer Reports review, in which the magazine said the car has "more than its share of problems." The publication praised the car for its design and smoothness, but is now also detailing various issues with a Model S that it has driven about 16,000 miles. Tesla points out that its warranty covered the issues mentioned and that Consumer Reports benefits, as any owner would, from its comprehensive warranty program.
JPMorgan Chase–The firm is selling about to Lexington Partners and a unit of Carlyle Group. One Equity is the bank's buyout unit, and the deal reportedly values JPMorgan's stake at about $2 billion, according to Dow Jones.
Rackspace–The company is forecasting current quarter revenue above analyst estimates, as demand for its cloud management services increases. Rackspace's second quarter earnings matched estimates, with revenue coming in above analyst forecasts.
—By CNBC's Peter Schacknow
Questions? Comments? Email us at firstname.lastname@example.org